aTyr Pharma, Inc.

NASDAQ:ATYR

Biotechnology

Healthcare
$0.53 +14.23%

+$0.07 today

Market cap
$52.13M
Beta
0.54
P/E (TTM)
-0.7
EPS (TTM)
-$0.71
52W Low $0.40High $7.29

Volume 1.02M

Average 2.29M

ATYR Income Before Tax

Profit after all operating and non-operating items but before income tax.

aTyr Pharma, Inc.NASDAQ: ATYR

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -$10.79M, compared with -$14.88M a year earlier. Trailing-twelve-month income before tax was -$70.03M.

Context

  • Income before tax amounted to 39009.5% of revenue in FY2025, up 11766.1 pp from a year earlier.
  • Income before tax grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income before tax holds near -$10.79M or moves back toward the trailing-twelve-month quarterly average of -$17.51M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$10.79M+22.7% QoQ
Last fiscal yearDec 2025
-$74.12M-15.8% YoY
LTMMar 2026
-$70.03M-10.4% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27.5%——
1 year-15.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(74.12M) USD
Year-over-year change
-15.8%

Income Before Tax vs competitors

How ATYR compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -10.4% is the 5th highest of 8, against a peer median of +7.7%.
  • Income before tax amounts to 36859.5% of revenue for ATYR, versus a peer median of 98.7%.
ATYR Competitors
Income Before Tax for ATYR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HYFTMindWalk Holdings Corp.LTM Jan 2026-CA$13.16M CAD+74.9%—71.7%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026-$39.95M USD-162.9%——
DTILPrecision BioSciences, Inc.LTM Mar 2026-$44.49M USD-102.3%—98.7%
RLMDRelmada Therapeutics, Inc.LTM Mar 2026-$58.88M USD+22.2%——
ATYRaTyr Pharma, Inc.LTM Mar 2026-$70.03M USD-10.4%—36859.5%
ACRVAcrivon Therapeutics, Inc. Common StockLTM Mar 2026-$77.27M USD+7.7%——
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026-$86.3M USD-66.7%—2193.7%
ALXOALX Oncology Holdings Inc.LTM Mar 2026-$88.87M USD+31.7%——
Peer median (excluding ATYR) —+7.7%—98.7%

Competitors are the stored peer set for ATYR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue010.39M353K235K190K
Cost of Revenue1.3M1.7M001.55M
Gross Profit(1.3M)8.69M353K235K(1.36M)
Gross Margin—83.7%100.0%100.0%-717.4%
Research & Development23.26M42.81M42.29M54.37M60.22M
Selling, General & Admin10.75M12.29M12.98M13.78M17.6M
Operating Expenses32.71M55.1M55.27M68.15M76.26M
Depreciation & Amortization1.3M1.7M2.74M1.54M1.55M
EBITDA(32.47M)(43.65M)(47.66M)(62.48M)(72.57M)
EBITDA Margin—-420.3%-13500.3%-26588.1%-38192.1%
Operating Income(34.02M)(46.4M)(54.92M)(67.91M)(77.63M)
Operating Margin—-446.8%-15557.8%-28899.6%-40856.3%
Interest Income00000
Interest Expense00000
Other Income / Expenses238K1.06M4.52M3.89M3.51M
Income Before Tax(33.78M)(45.34M)(50.4M)(64.02M)(74.12M)
Pre-Tax Margin—-436.6%-14276.8%-27243.4%-39009.5%
Income Tax Expense00000
Net Income(33.77M)(45.34M)(50.39M)(64.02M)(74.12M)
Net Margin—-436.5%-14274.5%-27243.8%-39009.5%
EPS (Basic)(1.77)(1.60)(0.94)(0.86)(0.80)
EPS (Diluted)(1.77)(1.60)(0.94)(0.86)(0.80)
Weighted Avg Shares19.08M28.42M53.61M74.26M92.99M
Weighted Avg Shares (Diluted)19.08M28.42M53.61M74.26M92.99M

aTyr Pharma, Inc.

NASDAQ:ATYR

Intrinsic Alpha fair value

Locked

Current Price

$0.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.